Company Encyclopedia
View More
name
INT'L GROUP
000411.SZ
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.
3.157 T
000411.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking129/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE10.70%B
    • Profit Margin1.47%C
    • Gross Margin6.86%E
  • Growth ScoreC
    • Revenue YoY1.90%C
    • Net Profit YoY3.12%C
    • Total Assets YoY5.84%B
    • Net Assets YoY6.98%B
  • Cash ScoreB
    • Cash Flow Margin6802.27%A
    • OCF YoY1.90%C
  • Operating ScoreA
    • Turnover1.99A
  • Debt ScoreD
    • Gearing Ratio69.03%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pharmaceutical commercial stocks are repeatedly active, NEPTUNUS has a 6-day consecutive limit-up, Realcan hits the limit-up, HRPC, SHKK, INT'L GROUP, and others follow suit. In news, China's drug price registration system has officially launched

    Wallstreetcn·
    SH
    600829
    +2.07%
    SH
    600272
    -5.70%
    SZ
    000411
    -0.87%
    Wallstreetcn·
    SH
    600829
    +2.07%
    SH
    600272
    -5.70%
    SZ
    000411
    -0.87%

    INT'L GROUP: Net profit for the third quarter was 73.9815 million yuan, a decrease of 24.19%

    INT'L GROUP announced that its revenue for the third quarter was 8.334 billion yuan, an increase of 2.05% year-on-year; net profit was 73.9815 million yuan, a decrease of 24.19%. Revenue for the first three quarters was 24.963 billion yuan, an increase of 0.75% year-on-year; net profit was 323 million yuan, a decrease of 9.15%

    Zhitong·
    SZ
    000411
    -0.87%
    Zhitong·
    SZ
    000411
    -0.87%

    INT'L GROUP plans to participate in the auction for 100% equity of Huatuo Pharmaceutical to enhance market share

    INT'L GROUP announced that its wholly-owned subsidiary, Zhejiang INT'L Pharmaceutical Co., Ltd., intends to participate in the auction for 100% equity of Huadong Pharmaceutical through the Zhejiang Property Exchange, with a listing reserve price of 369 million yuan. This move aims to enhance the company's market share and industry concentration in Zhejiang Province, strengthen its bargaining power with upstream suppliers, and promote the company's high-quality development

    Zhitong·
    SZ
    000411
    -0.87%
    Zhitong·
    SZ
    000411
    -0.87%

    The pharmaceutical commercial sector has seen a short-term surge, with YIXINTANG hitting the limit up

    The pharmaceutical commercial sector saw a short-term surge, with YIXINTANG hitting the limit up, and Sinopharm Accord, NEPTUNUS, INT'L GROUP, ZHEJIANG ZHENYUAN, CQP, and others all rising

    Zhitong·
    SZ
    000411
    -0.87%
    SZ
    000705
    +0.90%
    SZ
    000950
    -0.18%
    Zhitong·
    SZ
    000411
    -0.87%
    SZ
    000705
    +0.90%
    SZ
    000950
    -0.18%

    INT'L GROUP released its first-quarter results, with a net profit attributable to shareholders of 101 million yuan, a year-on-year decrease of 5.70%

    According to the Zhitong Finance APP, INT'L GROUP released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 8.437 billion yuan, a year-on-year decrease of 1.87%. The net profit attributable to shareholders of the listed company was 101 million yuan, a year-on-year decrease of 5.70%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 98.678 million yuan, a year-on-year decrease of 4.54%

    Zhitong·
    SZ
    000411
    -0.87%
    Zhitong·
    SZ
    000411
    -0.87%
    © 2025 Longbridge｜Disclaimer